
ALT This image is a slide detailing information from a study titled "OPTIMAL-STROKE: Intensive Blood-Pressure Control in Patients with Previous Ischemic Stroke." The slide includes the objective, study design, and conclusions. The study aims to investigate intensive blood pressure control's effect on cardiovascular risk after cerebrovascular events, with a design of an open-label, randomized study involving 4,368 participants. Results suggest that targeting a systolic BP of less than 120 mm Hg lowers the incidence of major cardiovascular events compared to 140 mm Hg in patients with previous ischemic stroke or transient ischemic attack. The logo of the American Heart Association is in the bottom left corner.

ALT A graph from the Original Article "Discontinuing Statins in Older Adults without Cardiovascular Disease." The trial name, STREAM, is in parentheses after the title. The graph shows estimated cumulative incidence of primary-outcome events. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.

ALT A graph from the Original Article "Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease." The trial name, ZEUS, is in parentheses after the title. The graph shows the cumulative incidence of 3-point MACE (composite primary end point). The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.

ALT A graph from the Original Article " Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a).” The trial name, Lp(a)HORIZON, is in parentheses after the title. The graph shows four-component MACE in full population with lipoprotein(a) level 70 mg/dl. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.






























